Cutiecaine

Product NDC
50876-111
11-digit product format
508760111
Labeler code
50876
Product ID
50876-111_e52c45c0-5dea-4d96-91c6-ec981065ce13
Type
HUMAN OTC DRUG
Nonproprietary name
Topical Lidocaine (4% w/w)
Dosage form
CREAM
Route
TOPICAL
Labeler
Innovatech Inc
Application
part348
Marketing category
OTC MONOGRAPH NOT FINAL
Marketing start
2010-05-31
Marketing end
0000-00-00
Substance
LIDOCAINE HYDROCHLORIDE
Active strength
40 mg/g
NDC exclude flag
E
Listing certified through
2017-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct50876-111IInactivated by FDA2026-10-12
excluded packagepackage50876-11150876-111-02IInactivated by FDA2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage50876-111-02d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage50876-111-02f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage50876-111-022ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage50876-111-02a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage50876-111-02cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage50876-111-02cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage50876-111-02302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage50876-111-02ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage50876-111-020efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage50876-111-02ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage50876-111-02367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage50876-111-02557ba5c1ecfa…9c80585c8c6e…
2024-05-28 21:12 UTC · source 2024-05-28excluded productproduct8af77b9d5b6f…d9bbb34c5368…
2024-05-28 21:12 UTC · source 2024-05-28excluded packagepackage50876-111-028af77b9d5b6f…d9bbb34c5368…
2024-05-15 03:39 UTC · source 2024-05-14excluded productproduct834df4deac94…adcc014656a3…
2024-05-15 03:39 UTC · source 2024-05-14excluded packagepackage50876-111-02834df4deac94…adcc014656a3…
2024-03-11 06:39 UTC · source 2024-03-08excluded productproduct1332a3947898…d4bfe170f9cd…
2024-03-11 06:39 UTC · source 2024-03-08excluded packagepackage50876-111-021332a3947898…d4bfe170f9cd…
2022-08-30 03:57 UTC · source 2022-08-29excluded productproductfb8cb913e6d1…eb8c232b6be0…
2022-08-30 03:57 UTC · source 2022-08-29excluded packagepackage50876-111-02fb8cb913e6d1…eb8c232b6be0…
2022-04-09 23:13 UTC · source 2022-04-08excluded productproduct86f5da6cb304…a595104c45d7…
2022-04-09 23:13 UTC · source 2022-04-08excluded packagepackage50876-111-0286f5da6cb304…a595104c45d7…
2022-04-04 05:40 UTC · source 2022-04-01excluded productproductbd6a592717d7…303034d00443…
2022-04-04 05:40 UTC · source 2022-04-01excluded packagepackage50876-111-02bd6a592717d7…303034d00443…
2021-12-27 23:28 UTC · source 2021-12-27excluded productproduct8dfbde2a14a4…c9ff85d89658…
2021-12-27 23:28 UTC · source 2021-12-27excluded packagepackage50876-111-028dfbde2a14a4…c9ff85d89658…
2020-12-18 03:04 UTC · source 2020-12-17excluded productproducte2bbac7714bc…27bdfed8d636…
2020-12-18 03:04 UTC · source 2020-12-17excluded packagepackage50876-111-02e2bbac7714bc…27bdfed8d636…
2020-06-10 20:45 UTC · source 2020-06-10excluded productproduct9bebd1f3094a…5416666fcb17…
2020-06-10 20:45 UTC · source 2020-06-10excluded packagepackage50876-111-029bebd1f3094a…5416666fcb17…
2019-12-08 06:16 UTC · source 2019-12-05excluded productproduct110d247fa046…a55b01930146…
2019-12-08 06:16 UTC · source 2019-12-05excluded packagepackage50876-111-02110d247fa046…a55b01930146…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
860a93dc-4863-49cc-b284-6bbe8191bc48Product name420250214
9b4cf230-fd05-41d5-98c6-5db9ecb27b86Product name120230117
68ed98f8-24c2-44a0-944a-6d36e82ce25aProduct name120141222
1cd42bc2-a430-c72b-636d-991b235fbf80Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
50876-111-022019-10-21C16284748780-1956f9ecf-d3d4-621f-e053-dbdaa90a74adDrug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50876-111-01Cutiecaine15 g in 1 TUBECREAM151
50876-111-02Cutiecaine1 in 1 CARTONCREAM11

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
LIDOCAINE HYDROCHLORIDEACTIVE INGREDIENTV13007Z41ACUTIECAINE (TOPICAL LIDOCAINE (4% W/W)) CREAM [INNOVATECH INC]1
LIDOCAINEACTIVE MOIETY98PI200987CUTIECAINE (TOPICAL LIDOCAINE (4% W/W)) CREAM [INNOVATECH INC]1
ALCOHOLINACTIVE INGREDIENT3K9958V90MCUTIECAINE (TOPICAL LIDOCAINE (4% W/W)) CREAM [INNOVATECH INC]1
ALOEINACTIVE INGREDIENTV5VD430YW9CUTIECAINE (TOPICAL LIDOCAINE (4% W/W)) CREAM [INNOVATECH INC]1
BUTYLENE GLYCOLINACTIVE INGREDIENT3XUS85K0RACUTIECAINE (TOPICAL LIDOCAINE (4% W/W)) CREAM [INNOVATECH INC]1
CARBOMER HOMOPOLYMER TYPE CINACTIVE INGREDIENT4Q93RCW27ECUTIECAINE (TOPICAL LIDOCAINE (4% W/W)) CREAM [INNOVATECH INC]1
CASTOR OILINACTIVE INGREDIENTD5340Y2I9GCUTIECAINE (TOPICAL LIDOCAINE (4% W/W)) CREAM [INNOVATECH INC]1
CETYL ALCOHOLINACTIVE INGREDIENT936JST6JCNCUTIECAINE (TOPICAL LIDOCAINE (4% W/W)) CREAM [INNOVATECH INC]1
GLYCERININACTIVE INGREDIENTPDC6A3C0OXCUTIECAINE (TOPICAL LIDOCAINE (4% W/W)) CREAM [INNOVATECH INC]1
HYALURONATE SODIUMINACTIVE INGREDIENTYSE9PPT4THCUTIECAINE (TOPICAL LIDOCAINE (4% W/W)) CREAM [INNOVATECH INC]1
ISOPROPYL ALCOHOLINACTIVE INGREDIENTND2M416302CUTIECAINE (TOPICAL LIDOCAINE (4% W/W)) CREAM [INNOVATECH INC]1
POLYSORBATE 20INACTIVE INGREDIENT7T1F30V5YHCUTIECAINE (TOPICAL LIDOCAINE (4% W/W)) CREAM [INNOVATECH INC]1
SODIUM LAURYL SULFATEINACTIVE INGREDIENT368GB5141JCUTIECAINE (TOPICAL LIDOCAINE (4% W/W)) CREAM [INNOVATECH INC]1
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APCUTIECAINE (TOPICAL LIDOCAINE (4% W/W)) CREAM [INNOVATECH INC]1
WATERINACTIVE INGREDIENT059QF0KO0RCUTIECAINE (TOPICAL LIDOCAINE (4% W/W)) CREAM [INNOVATECH INC]1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50876-111CUTIECAINE (TOPICAL LIDOCAINE (4% W/W)) CREAM [INNOVATECH INC]1Legacy NDC, 2 package rows20100531_e3043645-67fa-4e1b-9a75-b8b908b49756.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1046512Cutiecaine 4 % Topical CreamPSNe3043645-67fa-4e1b-9a75-b8b908b497561
1010895lidocaine HCl 4 % Topical CreamPSNe3043645-67fa-4e1b-9a75-b8b908b497561
1046512lidocaine hydrochloride 40 MG/ML Topical Cream [Cutiecaine]SBDe3043645-67fa-4e1b-9a75-b8b908b497561
1010895lidocaine hydrochloride 40 MG/ML Topical CreamSCDe3043645-67fa-4e1b-9a75-b8b908b497561
1046512Cutiecaine 4 % Topical CreamSYe3043645-67fa-4e1b-9a75-b8b908b497561
1046512Cutiecaine 40 MG/ML Topical CreamSYe3043645-67fa-4e1b-9a75-b8b908b497561
1010895lidocaine hydrochloride 4 % Topical CreamSYe3043645-67fa-4e1b-9a75-b8b908b497561

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsStatus
50876-111-015087601110115 g in 1 TUBE15 gHistorical
50876-111-02508760111021 in 1 CARTONHistorical